Down-staging of hepatocellular carcinoma via external-beam radiotherapy with subsequent liver transplantation: A case report
Authors:
- 1 October 2013
- journal article
- case report
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 19 (10) , 1119-1124
Abstract
Despite the widespread use of locoregional therapies [radiofrequency ablation and transarterial chemoembolization (TACE)], there is currently a lack of high-quality evidence supporting their use for hepatocellular carcinoma (HCC) in patients on the liver transplantation (LT) waiting list or requiring down-staging. Radiotherapy has rarely been used in this setting and has usually been in the form of more complex and less accessible techniques such as proton-beam and stereotactic body radiation therapy. Only 1 report describes the use of conventional 3-dimensional conformal external-beam radiotherapy (cEBRT) techniques as neoadjuvant or down-staging therapy for patients who are LT candidates. This report describes the use of cEBRT in a 52-year-old hepatitis C–positive man with cirrhosis. A 40-mm right lobe HCC was treated initially with TACE while he was on the waiting list. The lesion progressed beyond transplant criteria (76 mm). Conventional external-beam radiotherapy (EBRT) was used (54 Gy in 27 fractions) to down-stage the lesion. EBRT was well tolerated and resulted in a complete radiological response with no arterial enhancement of the lesion for a total of 16 months. Subsequent LT and a review of the explant demonstrated complete histological necrosis of the lesion. This report provides the first description of complete histological necrosis of HCC through the use of cEBRT techniques as down-staging/neoadjuvant therapy before LT. Because of its potential efficacy, accessibility, tolerability, noninvasive and outpatient nature, and ability to treat lesions adjacent to vessels and biliary structures, further trials examining the efficacy of cEBRT versus other neoadjuvant techniques are urgently required. Liver Transpl 19:1119–1124, 2013. © 2013 AASLD.Keywords
This publication has 12 references indexed in Scilit:
- Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantationLiver Transplantation, 2012
- The safety and efficacy of high‐dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trialCancer, 2011
- Radiotherapy for hepatocellular carcinoma: Systematic review of radiobiology and modeling projections indicate reconsideration of its useJournal of Gastroenterology and Hepatology, 2010
- Radiotherapy as a bridge to liver transplantation for hepatocellular carcinomaTransplant International, 2010
- Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies—mature results of the French Phase II RTF-1 trialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Radiation therapy for hepatocellular carcinomaCancer, 2006
- Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD eraLiver Transplantation, 2006
- Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver diseaseInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Dose-response relationship in local radiotherapy for hepatocellular carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Analysis of radiation-induced liver disease using the Lyman NTCP modelInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002